Literature DB >> 26145389

Hepatitis B screening and vaccination: how does a Sexual Health service measure up?

Ruthy McIver1, Amalie Dyda2, Vickie Knight1, Rebecca Guy2, Anna McNulty1.   

Abstract

Hepatitis B virus (HBV) is a vaccine-preventable disease. Sexual health clinics in New South Wales see a high caseload of populations at risk of HBV, and thus screening and vaccination are part of routine care. Uptake of screening and vaccination at Sydney Sexual Health Centre was assessed and it was found that among 1577 new patients with an elevated risk of HBV infection, 864 (55%) were potentially susceptible. Of those susceptible, the majority were screened (76%) and approximately one-third (35%) were found to be eligible for vaccination. The majority (83%) initiated vaccination. Of concern, however, is that incremental gaps between initiation and completion of the vaccine course resulted in an overall HBV vaccine coverage of 26% among those HBV susceptible.

Entities:  

Year:  2015        PMID: 26145389     DOI: 10.1071/SH15061

Source DB:  PubMed          Journal:  Sex Health        ISSN: 1448-5028            Impact factor:   2.706


  2 in total

1.  A cross-sectional sero-survey on preoperative HBV vaccination policy in Poland.

Authors:  Maria Ganczak; Marcin Korzen; Alina Jurewicz; Zbigniew Szych
Journal:  BMC Infect Dis       Date:  2017-07-25       Impact factor: 3.090

2.  Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low- and middle-income countries.

Authors:  Azumi Ishizaki; Julie Bouscaillou; Niklas Luhmann; Stephanie Liu; Raissa Chua; Nick Walsh; Sarah Hess; Elena Ivanova; Teri Roberts; Philippa Easterbrook
Journal:  BMC Infect Dis       Date:  2017-11-01       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.